drugset / Trial / NCT05746650

Improving Tissue Repair After Injury in the Muscle-tendon Interface Muscle Tissue Injury

NCT05746650

Recruiting 40 enrolled Bispebjerg Hospital
RandomizedParallel-groupTriple-blindBasic science

Summary

The study is a 2-week human study where 40 patients who are scheduled to undergo reconstructive knee surgery are randomized to administration of GH or placebo following or without neuromuscular electrical stimulation of hamstring muscles.The overall aim is to determine, the role of muscle connective tissue protein synthesis in muscle injury and repair.

Timeline

Start
2023-02-24
Primary completion
2027-06-01
Completion
2027-09-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Somatropin Protein / enzyme biologic 50 ug/kg

Indications

No indication recorded.